Skip to content
HowShorted

Global Blood Therapeutics, Inc. short interest in 2020

In 2020, Global Blood Therapeutics, Inc.'s disclosed short interest ran from 12.76% of shares outstanding on 15 Jan 2020 to 18.86% on 31 Dec 2020, a change of +6.10 percentage points. The year's high was 21.02% on 13 Nov 2020 and its low 11.98% on 31 Jan 2020, averaging 15.37% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.17 days on 31 Jul 2020. Full history: Global Blood Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for Global Blood Therapeutics, Inc. in 2020

2020 in figures

Start of year
12.76% (15 Jan 2020)
End of year
18.86% (31 Dec 2020)
Change
+6.10 pp
High
21.02% (13 Nov 2020)
Low
11.98% (31 Jan 2020)
Average
15.37%
Highest days to cover
20.17 (31 Jul 2020)
SEC filings marked
8

Every report in 2020

Global Blood Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202012.76%9.13
31 Jan 202011.98%7.89
14 Feb 202012.01%13.00
28 Feb 202012.28%9.1210-K filed, results (8-K)
13 Mar 202012.93%7.88
31 Mar 202015.85%8.79
15 Apr 202016.77%11.25
30 Apr 202015.69%10.93
15 May 202015.23%9.6510-Q filed, results (8-K)
29 May 202015.69%18.88
15 Jun 202016.67%14.71
30 Jun 202015.22%6.91
15 Jul 202014.77%13.29
31 Jul 202015.44%20.17
14 Aug 202014.82%11.0310-Q filed, results (8-K)
31 Aug 202014.30%19.90
15 Sep 202014.63%9.71
30 Sep 202015.10%12.68
15 Oct 202015.16%12.43
30 Oct 202015.57%14.15
13 Nov 202021.02%3.9210-Q filed, results (8-K)
30 Nov 202018.81%11.64
15 Dec 202017.40%7.48
31 Dec 202018.86%13.24

See also: Global Blood Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.